GlaxoSmithKline's Volibris drug receives positive recommendation
(ShareCast News) - A committee of the European Medicines Agency (EMA) has recommended GlaxoSmithKline's Volibris drug be approved for use in combination treatment for patients with pulmonary arterial hypertension. The Committee for Medicinal Products for Human Use (CHMP) announced the formal recomme
Read more